GTS Securities’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-37,900
Closed -$869K 2362
2024
Q3
$869K Buy
37,900
+7,900
+26% +$224K ﹤0.01% 2276
2024
Q2
$866K Sell
30,000
-1,100
-4% -$25.6K ﹤0.01% 2190
2024
Q1
$642K Buy
31,100
+5,200
+20% +$111K ﹤0.01% 2360
2023
Q4
$701K Buy
25,900
+11,800
+84% +$310K ﹤0.01% 2494
2023
Q3
$418K Buy
+14,100
New +$496K ﹤0.01% 2793

Other funds holding GH

GTS Securities's GH Position: Q4 2025 in Review

GTS Securities sold out of Guardant Health (GH) in Q4 2025, closing a stake of 4,028 shares — an estimated $252K sold.

GTS Securities first reported a position in GH in Q1 2024 and held it in 3 quarters. The position peaked at $559K in Q2 2024. 495 funds tracked by Wall St. Rank hold GH as of Q4 2025.

  • GTS Securities reported no remaining Guardant Health position as of Q4 2025 after selling out during the quarter.
  • GTS Securities sold 4,028 Guardant Health shares in Q4 2025, an estimated $252K.
  • GTS Securities first reported a position in Guardant Health in Q1 2024 and held it in 3 quarters.
  • GTS Securities's Guardant Health position peaked at $559K in Q2 2024.
  • 495 funds tracked by Wall St. Rank held Guardant Health as of Q4 2025.

Based on GTS Securities's 13F filing for Q4 2025, filed 13 Feb 2026.